Optimal Testing, Dosing, and Supplementation Protocol
Testing: request a 25-hydroxyvitamin D (25(OH)D) serum test — this is the standard clinical measure. Results interpretation: below 20 ng/mL = deficient; 20-30 ng/mL = insufficient; 30-40 ng/mL = adequate for basic bone health; 40-60 ng/mL = optimal for most health benefits (the range most research suggests is ideal); above 80 ng/mL = potentially excessive; above 150 ng/mL = toxic. Most people supplementing without testing land around 30-40 ng/mL, which is adequate but suboptimal. Testing enables precise titration. Testing should be done in late winter or early spring (when levels are typically at their seasonal nadir) for the most clinically useful baseline.
Supplementation dosing: the RDA for vitamin D (600-800 IU for adults) is widely considered insufficient to achieve optimal serum levels. To reach 40-60 ng/mL from a baseline of 20-25 ng/mL, most adults require 2000-5000 IU of vitamin D3 (cholecalciferol — more bioavailable than D2/ergocalciferol) daily. Obese individuals, older adults, and people with malabsorption conditions need higher doses (3000-6000 IU) due to impaired conversion efficiency. Take vitamin D3 with the largest meal of the day (fat-soluble vitamins are absorbed with dietary fat). Some people use weekly “loading” doses (50,000 IU once weekly for 8-12 weeks) under medical supervision to rapidly correct deficiency, then maintenance doses.
The vitamin D-K2 co-factor: vitamin K2 (menaquinone MK-7 from natto and certain cheeses, or MK-4 from animal products) works synergistically with vitamin D to direct calcium into bones rather than into arterial walls. Vitamin D increases intestinal calcium absorption; without K2’s activation of matrix Gla protein (MGP) and osteocalcin, the absorbed calcium may deposit in soft tissues and arteries (a potential concern with higher-dose vitamin D supplementation). Most vitamin D experts now recommend co-supplementing with 100-200 mcg of vitamin K2 (MK-7 form) when taking vitamin D3 at doses of 2000 IU+. The combination has the best evidence for both bone density and cardiovascular safety.
Sunlight optimization: 15-30 minutes of midday sun exposure on arms and legs (without sunscreen) can produce 10,000-20,000 IU of vitamin D3 in light-skinned individuals — far more than supplementation typically provides. However, this is only possible when the sun is high enough in the sky (UV Index ≥ 3), which in northern latitudes (above 37° north) doesn’t occur from approximately November through March. For people at lower latitudes year-round, regular moderate sun exposure is a legitimate strategy, but must be balanced against skin cancer risk. The safest approach: optimize supplementation year-round, and allow incidental sun exposure without being reliant on it for vitamin D status.